VELIN-PHARMA A/S: Financial statements 2022
CVR: 33026013
Source: annual report 2022, Danish Business Authority
01/06/2021 – 31/05/2022
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 439,912 and a net result of DKK 3,117,177 compared with DKK 5,954,072 the year before. That is an increase of 193% compared with the year before. Equity in the 2022 report amounted to DKK 31,241,465. The solvency ratio was 97.4%.
- Gross Profit
- DKK 439,912
- Profit/Loss
- DKK 3,117,177
- Equity
- DKK 31,241,465
- Total Assets
- DKK 32,076,043
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 440K | 3.1M | 31.2M | 0 |
| 2021 | - | 150K | 6M | 28.1M | 0 |
| 2020 | - | 279K | 3.5M | 22.2M | - |
| 2019 | - | 139K | -998K | 18.7M | - |
| 2018 | - | 86K | -807K | 19.7M | - |
Official annual report
Keep an eye on VELIN-PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.